|
CN1030415A
(zh)
*
|
1987-02-20 |
1989-01-18 |
山之内制药株式会社 |
饱和的杂环碳酰胺衍生物和它的制备方法
|
|
ES2005163A6
(es)
|
1987-04-14 |
1989-03-01 |
Lilly S A E |
Un procedimiento para la produccion de derivados de tiofen-2-carboxamida.
|
|
AU616488B2
(en)
|
1988-03-16 |
1991-10-31 |
Dr. Lo Zambeletti S.P.A. |
Heterocyclic derivatives
|
|
DE3810848A1
(de)
|
1988-03-30 |
1989-10-19 |
Boehringer Ingelheim Kg |
Neue 2,3,4-substituierte imidazole und 3,4,5-substituierte 1,2,4-triazole, ihre herstellung und verwendung
|
|
DE3927483A1
(de)
|
1989-08-19 |
1991-02-21 |
Boehringer Ingelheim Kg |
Neue substituierte heterocyclische fuenfringe, ihre herstellung und verwendung
|
|
DE3933573A1
(de)
|
1989-10-07 |
1991-04-18 |
Basf Ag |
Carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
|
|
US5258357A
(en)
*
|
1989-10-07 |
1993-11-02 |
Basf Aktiengesellschaft |
Carboxamides, their preparation and their use as herbicides
|
|
US6645969B1
(en)
*
|
1991-05-10 |
2003-11-11 |
Aventis Pharmaceuticals Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
|
|
US5559235A
(en)
|
1991-10-29 |
1996-09-24 |
Glaxo Wellcome Inc. |
Water soluble camptothecin derivatives
|
|
GB9201755D0
(en)
|
1992-01-28 |
1992-03-11 |
British Bio Technology |
Compounds
|
|
US5595872A
(en)
|
1992-03-06 |
1997-01-21 |
Bristol-Myers Squibb Company |
Nucleic acids encoding microsomal trigyceride transfer protein
|
|
US5342947A
(en)
|
1992-10-09 |
1994-08-30 |
Glaxo Inc. |
Preparation of water soluble camptothecin derivatives
|
|
US5786373A
(en)
|
1992-10-14 |
1998-07-28 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
AU678186B2
(en)
*
|
1992-10-23 |
1997-05-22 |
Merck Sharp & Dohme Limited |
Dopamine receptor subtype ligands
|
|
FR2707295A1
(fr)
|
1993-06-07 |
1995-01-13 |
Rhone Poulenc Agrochimie |
Fongicides pyrazoles substitués en position 3 par un hétérocycle.
|
|
JPH09501171A
(ja)
*
|
1993-08-06 |
1997-02-04 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
５ｈｔ１ｄ受容体アンタゴニストとしてのアミド誘導体
|
|
US5739135A
(en)
*
|
1993-09-03 |
1998-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of microsomal triglyceride transfer protein and method
|
|
US5681835A
(en)
|
1994-04-25 |
1997-10-28 |
Glaxo Wellcome Inc. |
Non-steroidal ligands for the estrogen receptor
|
|
US5491237A
(en)
|
1994-05-03 |
1996-02-13 |
Glaxo Wellcome Inc. |
Intermediates in pharmaceutical camptothecin preparation
|
|
US5668148A
(en)
*
|
1995-04-20 |
1997-09-16 |
Merck & Co., Inc. |
Alpha1a adrenergic receptor antagonists
|
|
JP3964478B2
(ja)
*
|
1995-06-30 |
2007-08-22 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
|
|
US5846990A
(en)
*
|
1995-07-24 |
1998-12-08 |
Bristol-Myers Squibb Co. |
Substituted biphenyl isoxazole sulfonamides
|
|
JPH10507205A
(ja)
*
|
1995-08-02 |
1998-07-14 |
ホータ．ウリアッヒ イ シイア．エセ．アー． |
抗真菌活性を有する新規カルボンアミド
|
|
DK0783501T3
(da)
*
|
1995-08-02 |
2001-01-29 |
Uriach & Cia Sa J |
Pyrimidonderivater med anti-fungal aktivitet
|
|
KR100284382B1
(ko)
*
|
1995-08-22 |
2001-03-02 |
미즈노 마사루 |
아미드화합물 및 그의 용도
|
|
US6001866A
(en)
|
1995-10-05 |
1999-12-14 |
Warner-Lambert Company |
Method for treating and preventing inflammation and atherosclerosis
|
|
US5972980A
(en)
|
1995-10-05 |
1999-10-26 |
Warner-Lambert Company |
Method for treating and preventing inflammation and atherosclerosis
|
|
WO1997012613A1
(en)
*
|
1995-10-05 |
1997-04-10 |
Warner-Lambert Company |
Method for treating and preventing inflammation and atherosclerosis
|
|
US5942544A
(en)
*
|
1996-02-22 |
1999-08-24 |
Dupont Pharmaceuticals Company |
α-branched anilines, toluenes, and analogs thereof as factor Xa inhibitors
|
|
CA2249645A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
CA2250936A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
JP2000507956A
(ja)
|
1996-04-03 |
2000-06-27 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル−タンパク質トランスフェラーゼ阻害剤
|
|
AU716123B2
(en)
|
1996-04-03 |
2000-02-17 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997036890A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
CA2249650A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
AU716381B2
(en)
|
1996-04-03 |
2000-02-24 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997036901A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
AU714851B2
(en)
|
1996-04-03 |
2000-01-13 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
AUPO163896A0
(en)
*
|
1996-08-14 |
1996-09-05 |
Resmed Limited |
Determination of respiratory airflow
|
|
WO1998037068A1
(en)
*
|
1997-02-21 |
1998-08-27 |
Bristol-Myers Squibb Company |
Benzoic acid derivatives and related compounds as antiarrhythmic agents
|
|
US5998336A
(en)
|
1997-02-26 |
1999-12-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Ceramic/metal and A15/metal superconducting composite materials exploiting the superconducting proximity effect and method of making the same
|
|
WO1998054164A1
(en)
*
|
1997-05-30 |
1998-12-03 |
Takeda Chemical Industries, Ltd. |
Sulfonamide derivatives, their production and use
|
|
GB9716557D0
(en)
|
1997-08-06 |
1997-10-08 |
Glaxo Group Ltd |
Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity
|
|
DE19744026A1
(de)
|
1997-10-06 |
1999-04-08 |
Hoechst Marion Roussel De Gmbh |
Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
|
|
AU751139B2
(en)
|
1997-10-13 |
2002-08-08 |
Astellas Pharma Inc. |
Amide derivative
|
|
DE19882893T1
(de)
|
1997-12-12 |
2001-02-22 |
Euro Celtique Sa |
Herstellung von 3-substituierten Adeninen
|
|
US6232320B1
(en)
*
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
AUPP433398A0
(en)
|
1998-06-25 |
1998-07-16 |
Australian National University, The |
Compounds and processes
|
|
US6192967B1
(en)
*
|
1998-10-19 |
2001-02-27 |
Sunny En Liung Huang |
Collapsible auto shade
|
|
US6130333A
(en)
|
1998-11-27 |
2000-10-10 |
Monsanto Company |
Bicyclic imidazolyl derivatives as phosphodiesterase inhibitors, pharmaceutical compositions and method of use
|
|
GB9827882D0
(en)
|
1998-12-17 |
1999-02-10 |
Smithkline Beecham Plc |
Novel compounds
|
|
DE19904397A1
(de)
|
1999-02-04 |
2000-08-10 |
Bayer Ag |
Verwendung von Pyrazol-Carbonsäureamiden
|
|
DE19904396A1
(de)
|
1999-02-04 |
2000-08-10 |
Bayer Ag |
Substituierte Pyrazolbenzylamin-Derivate
|
|
JP2000256358A
(ja)
|
1999-03-10 |
2000-09-19 |
Yamanouchi Pharmaceut Co Ltd |
ピラゾール誘導体
|
|
CA2368049A1
(en)
|
1999-04-13 |
2000-10-19 |
Basf Aktiengesellschaft |
Integrin receptor ligands
|
|
WO2000071493A2
(en)
*
|
1999-05-24 |
2000-11-30 |
Cor Therapeutics, Inc. |
INHIBITORS OF FACTOR Xa
|
|
JP2003500383A
(ja)
*
|
1999-05-24 |
2003-01-07 |
コア・セラピューティクス，インコーポレイテッド |
第Ｘａ因子阻害剤
|
|
JP2001247569A
(ja)
|
1999-08-12 |
2001-09-11 |
Japan Tobacco Inc |
ピロリジン誘導体又はピペリジン誘導体及びその医薬用途
|
|
US6632815B2
(en)
*
|
1999-09-17 |
2003-10-14 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
|
EP1235807A1
(en)
|
1999-11-24 |
2002-09-04 |
Millennium Pharmaceuticals, Inc. |
B-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factor xa
|
|
SK13752001A3
(sk)
|
1999-12-27 |
2002-07-02 |
Japan Tobacco, Inc. |
Zlúčeniny s fúzovanými kruhmi a ich použitie ako liečiv
|
|
US6770666B2
(en)
|
1999-12-27 |
2004-08-03 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs
|
|
CA2369076A1
(en)
|
2000-02-05 |
2001-08-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of erk
|
|
CZ20013540A3
(cs)
*
|
2000-02-05 |
2002-03-13 |
Vertex Pharmaceuticals Incorporated |
Deriváty pyrazolu jako inhibitory ERK a farmaceutický prostředek, který je obsahuje
|
|
AU2001236720A1
(en)
|
2000-02-05 |
2001-08-14 |
Bemis, Guy |
Compositions useful as inhibitors of erk
|
|
CA2401778C
(en)
*
|
2000-02-29 |
2010-12-21 |
Cor Therapeutics, Inc. |
Benzamides and related inhibitors of factor xa
|
|
GB0011098D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Pharmaceutical compositions comprising protpn pump inhibitors and gastrin/cholecystokinin receptor ligands
|
|
US6914069B2
(en)
*
|
2000-05-19 |
2005-07-05 |
Applied Research Systems Ars Holding N.V. |
Pharmaceutically active compounds and methods of use
|
|
US6589195B1
(en)
*
|
2000-05-26 |
2003-07-08 |
Orthomerica Products, Inc. |
Modular adjustable prophylactic hip orthosis and adduction/abduction joint
|
|
CA2409762A1
(en)
*
|
2000-06-23 |
2002-01-03 |
Donald J.P. Pinto |
Heteroaryl-phenyl substituted factor xa inhibitors
|
|
AU2001277143A1
(en)
|
2000-07-24 |
2002-02-05 |
Davide Riccardo Grassetti |
Inhibition of mutagenic effects of carcinogens
|
|
GB0018758D0
(en)
*
|
2000-07-31 |
2000-09-20 |
Smithkline Beecham Plc |
Novel use and compunds
|
|
JO2654B1
(en)
*
|
2000-09-04 |
2012-06-17 |
شركة جانسين فارماسوتيكا ان. في |
Multiple aryl caroxa amides are useful as lipid - lowering agents
|
|
WO2002064136A2
(en)
*
|
2001-01-26 |
2002-08-22 |
Chugai Seiyaku Kabushiki Kaisha |
Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
|
|
EP1390353A1
(en)
*
|
2001-04-27 |
2004-02-25 |
Vertex Pharmaceuticals Incorporated |
Triazole-derived kinase inhibitors and uses thereof
|
|
DE10223912A1
(de)
*
|
2001-06-28 |
2003-01-16 |
Merck Patent Gmbh |
TN- und STN-Flüssigkristallanzeigen
|
|
US20030015823A1
(en)
*
|
2001-07-18 |
2003-01-23 |
Hydranautics |
Method for forming a thick section, thermoset, solid casting
|
|
WO2003011855A2
(en)
|
2001-08-03 |
2003-02-13 |
Vertex Pharmaceuticals Incorporated |
Pyrazole-derived kinase inhibitors and uses thereof
|
|
CA2456187A1
(en)
|
2001-08-03 |
2003-02-13 |
Qing Tang |
Pyrazole-derived kinase inhibitors and uses thereof
|
|
US6562816B2
(en)
*
|
2001-08-24 |
2003-05-13 |
Pharmacia & Upjohn Company |
Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease
|
|
JP2005504093A
(ja)
*
|
2001-09-27 |
2005-02-10 |
アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ |
内因性テストステロンレベルの増加方法
|
|
US6794252B2
(en)
*
|
2001-09-28 |
2004-09-21 |
Texas Instruments Incorporated |
Method and system for forming dual work function gate electrodes in a semiconductor device
|
|
WO2003035619A1
(en)
|
2001-10-25 |
2003-05-01 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US6897208B2
(en)
*
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
|
WO2003039529A1
(en)
|
2001-11-07 |
2003-05-15 |
4Sc A.G. |
Selective antibacterial agents
|
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
JP4656838B2
(ja)
|
2002-02-06 |
2011-03-23 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｇｓｋ−３の阻害剤として有用なヘテロアリール化合物
|
|
US7335779B2
(en)
|
2002-03-08 |
2008-02-26 |
Quonova, Llc |
Modulation of pathogenicity
|
|
GB0206860D0
(en)
*
|
2002-03-22 |
2002-05-01 |
Glaxo Group Ltd |
Compounds
|
|
GB0206861D0
(en)
*
|
2002-03-22 |
2002-05-01 |
Glaxo Group Ltd |
Medicaments
|
|
CA2480856A1
(en)
|
2002-04-05 |
2003-10-23 |
Merck & Co., Inc. |
Substituted aryl amides
|
|
EP1507535A1
(en)
*
|
2002-04-26 |
2005-02-23 |
Pfizer Products Inc. |
Pyrimidine-2,4,6-trione metallo-proteinase inhibitors
|
|
JP2005529328A
(ja)
*
|
2002-06-05 |
2005-09-29 |
ファーマシア アンド アップジョン カンパニー |
競合的結合１ｈｎｍｒ実験を用いたリガンドの同定方法
|
|
GB0216224D0
(en)
*
|
2002-07-12 |
2002-08-21 |
Glaxo Group Ltd |
Compounds
|
|
RU2005105696A
(ru)
*
|
2002-08-02 |
2005-11-10 |
Арджента Дискавери Лимитед (Gb) |
Замещенные тиенилгидроксамовые кислоты в качестве ингибиторов гистондеацетилазы
|
|
TW200812986A
(en)
*
|
2002-08-09 |
2008-03-16 |
Nps Pharma Inc |
New compounds
|
|
US6649638B1
(en)
*
|
2002-08-14 |
2003-11-18 |
Ppd Discovery, Inc. |
Prenylation inhibitors and methods of their synthesis and use
|
|
WO2004016592A1
(en)
|
2002-08-14 |
2004-02-26 |
Ppd Discovery, Inc. |
Prenylation inhibitors and methods of their synthesis and use
|
|
DE60333762D1
(de)
|
2002-08-23 |
2010-09-23 |
Novartis Vaccines & Diagnostic |
Pyrrolverbindungen als glykogen synthase kinase 3 inhibitoren
|
|
DE10239443A1
(de)
|
2002-08-28 |
2004-03-11 |
Boehringer Ingelheim International Gmbh |
Blockiervorrichtung für ein Sperrspannwerk mit federbetätigtem Abtrieb
|
|
EP1398029A1
(en)
*
|
2002-09-10 |
2004-03-17 |
LION Bioscience AG |
NR3B1 nuclear receptor binding 3-substituted pyrazole derivatives
|
|
US20060084682A1
(en)
|
2002-12-13 |
2006-04-20 |
Heerding Dirk A |
Thrombopoietin mimetics
|
|
AU2003301226A1
(en)
*
|
2002-12-20 |
2004-07-22 |
Pharmacia Corp |
Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2
|
|
WO2004069805A1
(en)
*
|
2003-02-10 |
2004-08-19 |
Bayer Healthcare Ag |
Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
|
|
WO2004072018A1
(ja)
*
|
2003-02-12 |
2004-08-26 |
Takeda Pharmaceutical Company Limited |
アミン誘導体
|
|
US7223788B2
(en)
|
2003-02-14 |
2007-05-29 |
Sanofi-Aventis Deutschland Gmbh |
Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
|
|
CA2512886A1
(en)
*
|
2003-02-28 |
2004-09-10 |
Galderma Research & Development, S.N.C. |
Ligands that modulate lxr-type receptors
|
|
US7517887B2
(en)
|
2003-04-09 |
2009-04-14 |
General Atomics |
Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
|
|
AR044044A1
(es)
|
2003-04-21 |
2005-08-24 |
Elan Pharm Inc |
2-hidroxi-3-diaminoalcanos de benzamida
|
|
ES2351393T3
(es)
*
|
2003-05-26 |
2011-02-03 |
Takeda Pharmaceutical Company Limited |
Sulfopirroles.
|
|
WO2004113331A1
(en)
|
2003-06-20 |
2004-12-29 |
Galderma Research & Development, S.N.C. |
Novel compounds that modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions
|
|
DE10331305A1
(de)
|
2003-07-10 |
2005-02-17 |
Siemens Ag |
Kommunikationssystem, Peer-to-Peer-Nachrichten-Filter-Rechner und Verfahren zum Verarbeiten einer Peer-to-Peer-Nachricht
|
|
FR2857666B1
(fr)
|
2003-07-15 |
2005-08-26 |
Oreal |
Composition tinctoriale comprenant a titre de coupleur un derive du furane et nouveaux derives du furane
|
|
BRPI0412805A
(pt)
|
2003-07-23 |
2006-09-26 |
Synta Pharmaceuticals Corp |
método para modular canais de ìon de cálcio ativado por liberação de ìon de cálcio
|
|
WO2005019200A2
(en)
|
2003-08-14 |
2005-03-03 |
Icos Corporation |
Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof
|
|
WO2005016920A1
(en)
|
2003-08-15 |
2005-02-24 |
Vertex Pharmaceuticals Incorporated |
Pyrrole compositions useful as inhibitors of c-met
|
|
WO2005019182A1
(en)
|
2003-08-20 |
2005-03-03 |
Bayer Healthcare Ag |
Pyrazolylmethylbenzamide derivatives as p2xt-receptor antagonists
|
|
EP1689393A4
(en)
*
|
2003-10-06 |
2008-12-17 |
Glaxo Group Ltd |
PREPARATION OF 1,7-DISUBSTITUTED AZABENZIMIDAZOLES AS KINASE INHIBITORS
|
|
EP1670466A4
(en)
|
2003-10-06 |
2007-04-25 |
Glaxo Group Ltd |
PREPARATION OF 1,6,7-TRISUBSTITUTED AZABENIC ZIMIDAZOLES AS KINASE-INHIBITORS
|
|
US20050165031A1
(en)
*
|
2003-11-13 |
2005-07-28 |
Ambit Biosciences Corporation |
Urea derivatives as ABL modulators
|
|
BRPI0416852A
(pt)
|
2003-11-21 |
2007-02-27 |
Array Biopharma Inc |
inibidores da quinase akt
|
|
WO2005077435A1
(en)
|
2004-01-19 |
2005-08-25 |
Atul Kumar |
A system for distending body tissue cavities by continuous flow irrigation
|
|
US20080293716A1
(en)
|
2004-01-30 |
2008-11-27 |
Smithkline Beecham Corporation |
Chemical Compounds
|
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
US7521473B2
(en)
|
2004-02-25 |
2009-04-21 |
Wyeth |
Inhibitors of protein tyrosine phosphatase 1B
|
|
JP2007531757A
(ja)
*
|
2004-03-30 |
2007-11-08 |
カイロン コーポレイション |
抗癌剤としての置換チオフェン誘導体
|
|
CN1934836A
(zh)
*
|
2004-03-30 |
2007-03-21 |
松下电器产业株式会社 |
内容中继服务器、内容中继系统、内容中继方法和采用该方法的程序
|
|
AU2005230847B2
(en)
|
2004-03-31 |
2012-11-08 |
Exelixis, Inc. |
Anaplastic lymphoma kinase modulators and methods of use
|
|
JP2005336172A
(ja)
|
2004-04-26 |
2005-12-08 |
Japan Tobacco Inc |
腎虚血再灌流障害治療又は予防薬
|
|
TW200600492A
(en)
*
|
2004-05-18 |
2006-01-01 |
Achillion Pharmaceuticals Inc |
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
|
|
WO2005116001A1
(en)
*
|
2004-05-29 |
2005-12-08 |
7Tm Pharma A/S |
Substituted thiazoleacetic as crth2 ligands
|
|
US20060135773A1
(en)
|
2004-06-17 |
2006-06-22 |
Semple Joseph E |
Trisubstituted nitrogen modulators of tyrosine phosphatases
|
|
WO2006004984A1
(en)
*
|
2004-06-30 |
2006-01-12 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of protein kinases
|
|
US7671077B2
(en)
*
|
2004-07-19 |
2010-03-02 |
Leu-Fen Hou Lin |
Neuroprotective small organic molecules, compositions and uses related thereto
|
|
US20060019967A1
(en)
*
|
2004-07-21 |
2006-01-26 |
Su-Ying Wu |
SARS CoV main protease inhibitors
|
|
US20060019968A1
(en)
*
|
2004-07-24 |
2006-01-26 |
Laboratorios Dr. Esteve S.A. |
Use of compounds active on the sigma receptor for the treatment of neuropathic pain
|
|
US7269099B2
(en)
|
2004-07-30 |
2007-09-11 |
Bolt Technology Corporation |
Air gun
|
|
JP2006066488A
(ja)
*
|
2004-08-25 |
2006-03-09 |
Mitsubishi Electric Corp |
半導体受光素子およびその製造方法
|
|
US7365385B2
(en)
*
|
2004-08-30 |
2008-04-29 |
Micron Technology, Inc. |
DRAM layout with vertical FETs and method of formation
|
|
US20060043513A1
(en)
*
|
2004-09-02 |
2006-03-02 |
Deok-Hoon Kim |
Method of making camera module in wafer level
|
|
TW200616969A
(en)
|
2004-09-17 |
2006-06-01 |
Tanabe Seiyaku Co |
Imidazole compound
|
|
US20060062453A1
(en)
*
|
2004-09-23 |
2006-03-23 |
Sharp Laboratories Of America, Inc. |
Color highlighting document image processing
|
|
WO2006043518A1
(ja)
|
2004-10-18 |
2006-04-27 |
Santen Pharmaceutical Co., Ltd. |
神経疾患治療剤
|
|
JP2006120339A
(ja)
|
2004-10-19 |
2006-05-11 |
Matsushita Electric Ind Co Ltd |
高周波加熱電源装置
|
|
TW200619843A
(en)
|
2004-10-20 |
2006-06-16 |
Sumitomo Bakelite Co |
Semiconductor wafer and semiconductor device
|
|
DE102004051277A1
(de)
|
2004-10-21 |
2006-04-27 |
Merck Patent Gmbh |
Heterocyclische Carbonylverbindungen
|
|
DE102004054666A1
(de)
|
2004-11-12 |
2006-05-18 |
Bayer Cropscience Gmbh |
Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
EP1814866A2
(en)
*
|
2004-11-23 |
2007-08-08 |
Wyeth a Corporation of the State of Delaware |
Gonadotropin releasing hormone receptor antagonists
|
|
JP2008521776A
(ja)
*
|
2004-11-30 |
2008-06-26 |
ノイロサーチ アクティーゼルスカブ |
コリン作動性リガンドとしての新規なジアザ二環式アリール誘導体
|
|
SE527990C2
(sv)
|
2004-12-06 |
2006-08-01 |
Mora Of Sweden Ab |
Isborr
|
|
EP1843763A2
(en)
|
2005-02-03 |
2007-10-17 |
Irm, Llc |
Compounds and compositions as ppar modulators
|
|
JP2006232707A
(ja)
|
2005-02-23 |
2006-09-07 |
Japan Tobacco Inc |
癌転移抑制剤
|
|
US20080207760A1
(en)
|
2005-04-11 |
2008-08-28 |
Achillion Pharmaceuticals, Inc. |
Pharmaceutical Compositions For and Methods of Inhibiting Hcv
|
|
US20060252807A1
(en)
*
|
2005-04-22 |
2006-11-09 |
Kalypsys, Inc. |
Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
WO2006136829A2
(en)
|
2005-06-21 |
2006-12-28 |
Astex Therapeutics Limited |
Pyrazole derivatives and their use as pka and pkb modulators
|
|
US20060288588A1
(en)
|
2005-06-22 |
2006-12-28 |
Frank Morabito |
Garden tool
|
|
US8541461B2
(en)
*
|
2005-06-23 |
2013-09-24 |
Astex Therapeutics Limited |
Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
|
|
AU2006261132A1
(en)
|
2005-06-24 |
2006-12-28 |
Genelabs Technologies, Inc. |
Heteroaryl derivatives for treating viruses
|
|
WO2006136637A2
(es)
*
|
2005-06-24 |
2006-12-28 |
Eloy Antonio Martinez Albal |
Implante dental de corona rotatoria
|
|
MX2008000141A
(es)
|
2005-06-27 |
2008-04-07 |
Exelixis Inc |
Moduladores de lxr basados en imidazol.
|
|
CN100494167C
(zh)
|
2005-08-02 |
2009-06-03 |
天津大学 |
抗乙肝病毒的叔胺氧化物及制备方法和制备药物的应用
|
|
GB0518237D0
(en)
|
2005-09-07 |
2005-10-19 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
|
US7838676B2
(en)
*
|
2005-11-21 |
2010-11-23 |
Amgen Inc. |
Beta-secretase modulators and methods of use
|
|
WO2007070818A1
(en)
|
2005-12-14 |
2007-06-21 |
Bristol-Myers Squibb Company |
Six-membered heterocycles useful as serine protease inhibitors
|
|
WO2007076423A2
(en)
|
2005-12-22 |
2007-07-05 |
Smithkline Beecham Corporation |
INHIBITORS OF Akt ACTIVITY
|
|
SI1962830T1
(sl)
|
2005-12-23 |
2013-07-31 |
Glaxosmithkline Llc |
Azaindolni inhibitorji kinaz Aurora
|
|
AR056882A1
(es)
|
2006-02-01 |
2007-10-31 |
Bayer Cropscience Sa |
Derivados del fungicida n- cicloalquil- bencil- amida
|
|
WO2007100851A1
(en)
|
2006-02-28 |
2007-09-07 |
Helicon Therapeutics, Inc. |
Therapeutic compounds
|
|
JP2007277230A
(ja)
|
2006-03-15 |
2007-10-25 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
|
US9562019B2
(en)
|
2006-12-21 |
2017-02-07 |
Sloan-Kettering Institute For Cancer Research |
Substituted pyridazines as EGFR and/or KRAS inhibitors
|
|
WO2008079371A1
(en)
|
2006-12-22 |
2008-07-03 |
Encysive Pharmaceuticals, Inc. |
Modulators of c3a receptor and methods of use thereof
|
|
UY30892A1
(es)
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
|
EP2114388B1
(en)
|
2007-02-07 |
2015-05-20 |
GlaxoSmithKline LLC |
Inhibitors of akt activity
|
|
WO2008121685A1
(en)
|
2007-03-28 |
2008-10-09 |
Smithkline Beecham Corporation |
Methods of use for inhibitors of akt activity
|
|
US8338434B2
(en)
|
2007-03-29 |
2012-12-25 |
Glaxosmithkline Llc |
Inhibitors of Akt activity
|